LASMIDITAN: New Acute migraine treatment

LASMIDITAN: New Acute migraine treatment

Lasmiditan is an oral medication for treatment of acute migraines. It is the first of its class of serotonin (5-HT)1F receptor agonists meaning that it acts on the chemical in our body called serotonin.

Two studies of lasmiditan found that patients had higher levels of pain relief compared to placebo after taking the medication and relief of migraine-associated symptoms 2 hours after taking it. There also may be particular benefit for patients who have nighttime migraines that interfere with sleep.

For more information about this medication call The Manhattan Center for Headache & Neurology. We look forward to meeting you!

 

By: Brooke Steiger, NP

May 26, 2025 Uncategorized

×

The Manhattan Center for Headache and Neurology is Permanently Closed

We are grateful to have been a part of your healthcare journey.

We will provide updated information about our providers and their future plans here as it becomes available.

If you have questions or would like to request your medical records, please email us at ahalpernmd.temp@gmail.com.

Further updates will be posted on this website.